Akt1 isoform modulates phenotypic conversion of vascular smooth muscle cells  by Yun, Sung Ji et al.
Biochimica et Biophysica Acta 1842 (2014) 2184–2192
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r .com/ locate /bbad isAkt1 isoform modulates phenotypic conversion of vascular smooth
muscle cellsSung Ji Yun a,b, Jung Min Ha a,b, Eun Kyoung Kim a,b, Young Whan Kim a,b, Seo Yeon Jin a,b, Dong Hyung Lee c,
Sang Heon Song d, Chi Dae Kim a,b, Hwa Kyoung Shin e, Sun Sik Bae a,⁎
a MRC for Ischemic Tissue Regeneration, Department of Pharmacology, Pusan National University School of Medicine, Yangsan, Republic of Korea
b Department of Pharmacology, Pusan National University School of Medicine, Yangsan, Republic of Korea
c Department of Obstetrics and Gynecology, Pusan National University School of Medicine, Yangsan, Republic of Korea
d Department of Internal Medicine, Pusan National University Hospital, Pusan National University School of Medicine, Yangsan, Republic of Korea
e Department of Anatomy, Pusan National University School of Korean Medicine, Yangsan, Republic of Korea⁎ Corresponding author at: MRC for Ischemic Tissue Re
PharmacologyPusan National University School of Medi
Yangsan-si, Kyungnam 626-870, Republic of Korea.
E-mail address: sunsik@pusan.ac.kr (S.S. Bae).
http://dx.doi.org/10.1016/j.bbadis.2014.08.014
0925-4439/© 2014 Elsevier B.V. All rights reserved.a b s t r a c ta r t i c l e i n f oArticle history:
Received 19 June 2014
Received in revised form 13 August 2014
Accepted 28 August 2014
Available online 6 September 2014
Keywords:
Akt
Laminin
Integrin-linked kinase
Neointima
Phenotypic changeIn this study, we investigated the role of Akt1 isoform in phenotypic change of vascular smooth muscle cells
(VSMCs) and neointima formation. Laminin-induced conversion of synthetic VSMCs into contractile VSMCs
wasmeasured by expression ofmarker proteins for contractile VSMCs and collagen gel contraction assay. Culture
of synthetic VSMCs on laminin-coated plates induced expression of marker proteins for contractile VSMCs and
showed contraction in response to angiotensin II (AngII) stimulation. Silencing integrin-linked kinase attenuated
activation of Akt and blocked phenotypic conversion of VSMCs resulting in the loss of AngII-dependent contrac-
tion. Laminin-induced phenotypic conversion of VSMCs was abrogated by phosphatidylinositol 3-kinase inhibi-
tor or in cells silencing Akt1 but not Akt2. Proliferation of contractile VSMCs on laminin-coated plate was
enhanced in cells silencing Akt1 whereas silencing Akt2 did not affect. Promoter activity of myocardin and
SM22α was enhanced in contractile phenotype and overexpression of myocardin stimulated promoter activity
of SM22α in synthetic phenotype. Promoter activity of myocardin and SM22α was reduced in cells silencing
Akt1 and promoter activity of SM22αwas restored by overexpression of myocardin in cells silencing Akt1. How-
ever, silencing of Akt2 affected neither promoter activity of myocardin nor SM22α. Finally, neointima formation
in carotid artery ligation and high fat-diet-induced atherosclerosiswas facilitated inmice lacking Akt1. This study
demonstrates that Akt1 isoform stimulates laminin-induced phenotypic conversion of synthetic VSMCs by regu-
lating the expression of myocardin. VSMCs become susceptible to shifting from contractile to synthetic pheno-
type by the loss of Akt1 in pathological conditions.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Vasoconstriction, vascular tone, blood pressure, and blood ﬂow
are controlled by the highly specialized vascular smooth muscle cells
(VSMCs). VSMCs halt proliferation and express specialized proteins
such as a repertoire of contractile proteins and ion channels [1]. In a
mature blood vessel, VSMCs display a contractile phenotype character-
ized by expression of speciﬁc marker proteins such as myosin heavy
chain (MHC), myosin light chain kinase (MLCK), smooth muscle actin
(SMA), SM22α, and calponin,which is an important protein for contrac-
tion [1]. Unlike cardiac or skeletal myocytes, terminally differentiated
VSMCs retain phenotypic plasticity and undergo reversible changes in
response to environmental stimuli. Such processes include loss of thegeneration, and Department of
cine, Bumeo-ri, Mulgeum-eup,physiological function of VSMCs and play key roles in the neointima for-
mation duringpathogenesis of atherosclerosis and restenosis during an-
gioplasty, stenting, or bypass surgery [2].
During embryonic development, contractile VSMCs originate from
embryonic stem cells or pericytes. In addition, the differentiation of
VSMCs is well characterized in vitro using mouse or human embryonic
stem cells (ESCs). For example, ESCs differentiate into either endothelial
cells (ECs) or VSMCs under appropriate conditions [3]. It also has been
reported that expression of myocardin, a cofactor for serum response
factor (SRF), plays key roles in the differentiation of VSMCs [4]. Expres-
sion of myocardin itself is regulated by variety of transcription factors
including Mef2, Tead, and Fox proteins [5]. Once VSMCs acquire differ-
entiated status, they need certain environmental cues to maintain dif-
ferentiated status. For instance, it has been reported that laminin and
insulin-like growth factor-1 (IGF-1) provide the ability of VSMCs to
maintain a contractile phenotype under in vitro culture conditions [6].
In the absence of such environmental cues, VSMCs rapidly display phe-
notypic changes [7]. Phenotypic conversion of VSMCs from contractile
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migration, and extracellular matrix synthesis and thereby cause intimal
thickening. Therefore, maintaining contractile phenotypes of VSMCs
seems to be important for healthy blood vessels.
The vessel architecture is mainly composed of ECs, VSMCs, adventi-
tialﬁbroblasts, and extracellularmatrix (ECM)molecules. Each cell rests
on basement membrane, which is a specialized structure composed of
ECM molecules such as laminins, collagens, elastin, and proteoglycans
[8]. Especially, the roles of ECM proteins in VSMC plasticity have been
investigated. Stimulation of contractile VSMC with plasma ﬁbronectin
strongly promoted a phenotypic change [9]. By contrast, culture of
contractile VSMCs on laminin-coated dish maintained the contractile
phenotype of VSMCs [10]. Therefore, interaction of VSMCs with ECM
proteins seems to be an important determinant in the phenotypic
changes of VSMCs. However, the signaling cascades involved in ECM-
dependent change of synthetic VSMCs into contractile VSMCs are large-
ly unknown.
ECM proteins bind to integrins, which are a large family of glycosyl-
ated, heterodimeric, and transmembrane proteins. Each heterodimer
consists of one α and one β subunit that associates non-covalently to
produce a functional receptor [11]. Once integrins are activated, their
cytoplasmic tails can bind numerous proteins, which in turn transduce
signaling cascades. Proteins that are involved in integrin signaling
include focal adhesion kinase (FAK), integrin-linked kinase (ILK),
paxillin, Src family kinases, and others [12]. ILK is a serine/threonine
protein kinase that binds to β subunit of integrins. ILK contains a
pleckstrin homology (PH) domain that binds phosphatidylinositol
3,4,5-trisphosphate (PIP3), which activates ILK activity via the phos-
phatidylinositol 3-kinase (PI3K) pathway. ILK also binds Akt and phos-
phorylates its Ser473 site [13]. ILK can inﬂuence a variety of cellular
physiologies such as survival, proliferation, migration, differentiation,
and epithelial–mesenchymal transition (EMT) [14]. The signiﬁcance of
the ECM-ILK interaction and its downstream signaling pathways in
the phenotypic change of VSMCs has not been fully elucidated yet.
Akt is serine/threonine kinase that regulates a variety of cellular re-
sponses. The Akt family of enzyme consists of three isozymes (Akt1,
Akt2, and Akt3) encoded by three different genes [15]. Although each
isoform shares ~85% homology in amino acid sequence, different
functions for each isoform have been implicated in targeted mice
models [16–18]. However, the role of Akt isoform in the phenotypic
change of VSMCs is still ambiguous. In the present study, we investigat-
ed the role of the ECM/ILK/Akt1 axis in the regulation of VSMC pheno-
types as well as in neointima formation during the pathogenesis of
atherosclerosis.2. Materials and methods
2.1. Materials
Anti-myosin heavy chain (MHC) antibody was obtained from
Proteintech Group Inc. (Chicago, IL, USA). Anti-myosin light chain ki-
nase (MLCK) antibodywas purchased from Epitomics, Inc. (Burlingame,
CA, USA). Antibodies against smoothmuscle actin (SMA), calponin, and
SM22α were obtained from Sigma-Aldrich (St Louis, MO, USA). Anti-
actin antibody was purchased from MP biomedicals (Aurora, OH,
USA). Anti-ERK1/2 and anti-p-Akt (Ser473) antibodies were obtained
from Cell Signaling Technology (Boston, MA, USA). Antibodies against
ILK, pan-Akt, Akt1, and Akt2 were purchased from Millipore Corpora-
tion (Billerica, MA, USA). AngII and laminin isolated from human pla-
centa were obtained from Sigma-Aldrich (St Louis, MO, USA). Type I
collagen was purchased from BD Biosciences (San Jose, CA, USA). The
promoter region of SM22α subcloned in pGL3 vector was a kind gift
from Dr. Gary K. Owens (University of Virginia). All other chemicals
were purchased from Sigma-Aldrich (St Louis, MO, USA) unless indicat-
ed elsewhere.2.2. Animals
Four-week-old male Sprague–Dawley rats were purchased from
Koatech Inc. (Pyungtak, Korea). Mice lacking Akt1 (Akt1−/−,
C57B6.129P2-Akt1tm1Mbb/J) and ApoE (ApoE−/−, C57B6.129P2-
Apoetm1Unc/J) were purchased from The Jackson Laboratory (Bar Harbor,
Maine, USA). Akt1−/− mice were crossed with ApoE-deﬁcient
mice (ApoE−/−) to generate heterozygous mice at both loci. Akt1+/−
ApoE−/− mice were intercrossed to produce Akt1+/+ApoE−/− and
Akt1−/−ApoE−/− littermates. Mice were housed under speciﬁc patho-
gen free (SPF) conditions. All animal procedures were done in accor-
dance with our institutional guidelines for animal research, and were
approved by our Institutional Animal Care and Use Committee (PNU-
2009-0008). The investigation conforms to the Guide for the Care and
Use of Laboratory Animals published by the US National Institutes of
Health (NIH Publication, 8th edition, 2011).
2.3. Cell preparation, culture, and induction of phenotypic conversion
Vascular smooth muscle cells (VSMCs) were isolated from 4-week-
old Sprague–Dawley rats by a tissue explanting method. Brieﬂy, rats
were euthanized via intraperitoneal injection of sodium pentobarbital
(60 mg/kg) and perfusedwith PBS for 5 min. Thoracic aorta was asepti-
cally isolated and the surrounding fat and connective tissues were
discarded. Vessels were longitudinally cut and the lumen side was
scrapedwith a razor blade to remove the intima. Vesselswere incubated
with collagenase solution (2 mg/ml) for 30 min and adventitial ﬁbro-
blast layer was peeled off. The media layer of vessels was fragmented
into 3–5 mm lengths and explanted lumen side down on collagen-
coated culture dishes. After seven days of explanting, tissue fragments
were discarded and sprouted VSMCs were collected (referred as P0).
Synthetic type of VSMCs was cultured on gelatin-coated plate at low
density (b20%). To induce phenotypic conversion of VSMCs, synthetic
type of VSMCs (P0) was cultured on laminin-coated plates at high den-
sity (~100%) and passages between P2 and P5 were deﬁned as contrac-
tile type of VSMCs.
2.4. Cell proliferation assay and cell cycle analysis
To measure cell proliferation, a total of 2500 VSMCs were seeded on
a six-well plate and grown for 5 days in normal culture medium. Cells
were ﬁxed with 4% paraformaldehyde, and the nuclei were stained
with DAPI. Stained cells were visualizedwith a ﬂuorescencemicroscope
and random images of four ﬁelds were taken at 20× magniﬁcation. To
analyze cell cycle, a total of 5 × 105 VSMCs were seeded on 100-mm
dish and serum-starved for 24 h to synchronize them in the G1 phase
of the cell cycle. Synchronous populations of cells were subsequently
treated in the absence or presence of 10% FBS for 18 h. Flow cytometry
analysis was performed using FACSCalibur (Becton Dickinson, San Jose,
CA). Datawere acquired and analyzedwith CellQuest software. The per-
centage of cells in each phase of the cell cycle was calculated as the ratio
of events in each phase to the total number of events.
2.5. Collagen gel contraction assay
VSMCs were isolated by trypsin digestion and resuspended in
serum-free DMEM (1 × 106 cells/ml). The cell suspension was mixed
on ice with collagen gel solution (8 mg/ml of collagen type I in 2×
PBS, pH 8.0) to give 5 × 105 cells/ml and 4 mg/ml of collagen gel solu-
tion. One hundred microliters of VSMC-collagen gel mixture was
added to 12-well plates. The plate was incubated at 37 °C to allow for
polymerization. After 30 min, the gels were ﬂoated in serum-free
DMEM; after 5 h, AngII was added to initiate contraction while images
were captured using a digital charge-coupled device camera. Collagen
gel contraction was measured as a decrease in gel area using Scion
Image software (compliments of Scion Corporation, Frederick, MD;
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the area at each time point by the initial area of the gel.
2.6. Short hairpin RNA and constructs
To silence Akt1, Akt2, and ILK, oligonucleotides taggedwith a 5′-end
AgeI site and a 3′-end EcoRI site were designed for sh-Akt1 (5′-CCG GTA
ACT TCT CAG TGG CAC AAT GCC TCG AGG CAT TGT GCC ACT GAG AAG
TTT TTT TG-3′), sh-Akt2 (5′-CCG GTG GTC ATC ATT GCA AAG GAT GAC
TCG AGT CAT CCT TTG CAA TGA TGA CCT TTT TG-3′), and sh-ILK (5′-
CCG GTG ACG CTC AGC AGA CAT GTG GAC TCG AGT CCA CAT GTC TGC
TGA GCG TCT TTT TG-3′) and both sense and anti-sense oligonucleo-
tideswere synthesized (XENOTECH,Daejeon, Korea). Both complemen-
tary oligonucleotides were mixed and heated at 98 °C for 5 min and
cooled to room temperature. Annealed nucleotides were subcloned
into the AgeI/EcoRI site of a pLKO.1 lentiviral vector.
2.7. Lentiviral knockdown
For gene silencing, HEK293-FT packaging cells (Invitrogen) were
grown to ~70% conﬂuence in 6-well plates. Cells were triple transfected
with 6 μg of pLKO.1 lentiviral construct, 1 μg ofΔ8.9, and 1 μg of pVSV-G
using a calcium phosphate method. Medium was replaced with fresh
medium 8 h post-transfection. Lentiviral supernatants were harvested
24 h post-transfection and passed through 0.45-μm ﬁlters. Cell-free
viral culture supernatants were used to infect synthetic VSMC in the
presence of 8 μg/ml of polybrene (Sigma). An additional round of infec-
tionwas done at 48 h and 72 h post-transfection. Infected cells were iso-
lated by selection with 10 μg/ml puromycin for 2 days.
2.8. Plasmids and promoter assay
To clone myocardin promoter, rat genomewas PCR-ampliﬁed using
forward primer, 5′-CGCTCGAGCAGCTCAGAGGTAGATGGATA-3′; and
reverse primer, 5′-CGAAGCTTAGGAGTGTCATGGTGAGTCTC-3′. The
XhoI and HindIII restriction enzyme sites are underlined. The promoter
fragment was ﬁnally cloned into the vector pGL3 basic (Promega). For
the measurement of promoter activity, the dual-luciferase reporter
assay system was employed. VSMCs were plated in 12-well plates.
Cells were co-transfected with the luciferase reporter constructs and
the renilla luciferase plasmids using Lipofectamine 2000 (Invitrogen).
Eachwell contained 0.88 μg of luciferase reporter plasmids, 0.8 μg of ex-
pression vectors, and 80 ng of renilla luciferase plasmids. Medium was
replaced with fresh medium 7 h post-transfection. The cells were
lysed and assayed for luciferase activity 24 h after post-transfection.
Twenty microliters of protein extracts were analyzed in a GloMaxTM
20/20 luminometer (Promega, WI, USA).
2.9. Western blotting and immunocytochemistry
For western blotting, cell lysates were subjected to SDS–polyacryl-
amide gel electrophoresis on 10% polyacrylamide gel under reducing
conditions. Proteins were transferred to nitrocellulose membranes,
which were subjected to immunoblotting using the indicated primary
antibodies and IRDye-conjugated secondary antibodies (Li-COR biosci-
ences). Western blots were developed using Odyssey (Li-COR biosci-
ences). For immunocytochemistry, cells were washed with ice-cold
PBS and ﬁxed with 4% paraformaldehyde for 10min. Cells were perme-
abilized with 0.2% Triton X-100, and incubated with indicated primary
antibody for 1 h followed by Cy3 or Alexa Fluor 488-conjugated second-
ary antibody for 30 min. Samples were mounted with anti-fading re-
agent (2% n-propyl gallate in 80% glycerol/PBS solution) and images
were obtained with confocal microscope (FV1000-ZDC, Olympus,
Japan).2.10. Carotid artery ligation, induction of atherosclerosis, and
immunohistochemistry
To induce neointima, the left common carotid artery of mouse was
ligated proximal to the bifurcation. After 4 weeks, both left and right
common carotid arteries were isolated. Atherosclerosis was induced
by feeding the mice a high-fat western-type diet containing 1.25% cho-
lesterol (Research Diets, D12108) for 15 weeks. Isolated carotid arteries
or aortas were ﬁxed in 4% paraformaldehyde at 4 °C overnight and em-
bedded in parafﬁn for immunohistochemistry. Five-millimeter sections
of each blockwere stainedwith hematoxylin & eosin (H&E), or the indi-
cated primary antibodies, and visualized with MIRAX MIDI Versatile
Digital Slide Scanner (Carl Zeiss, Jena, Germany) or confocal microscopy
(FV1000-ZDC, Olympus, Japan).
2.11. Statistical analysis
Results are expressed as themean±SDof three independent exper-
iments (n= 3 for each experiment). When comparing two groups, an
unpaired Student's t-test was used to assess differences. P-values less
than 0.05 were considered signiﬁcant.
3. Results
3.1. Phenotypic conversion of VSMCs by laminin
VSMCs exist as two different phenotypes: synthetic phenotype that
rapidly proliferates and the contractile phenotype that contracts in re-
sponse to extracellular stimuli. VSMCs isolated by explanting aortic tis-
sue fragments on collagen-coated plates (P0) showed low expression
levels of marker proteins for contractile VSMCs such as MHC, MLCK,
SMA, calponin, and SM22α while plating P0 cells on laminin-coated
plates initiated the expression of marker proteins for contractile
VSMCs (Fig. 1A and B). Phenotypic status was further conﬁrmed by
AngII-dependent contraction. As shown in Fig. 1C, AngII rapidly stimu-
lated contraction of P3-stage VSMCs, whereas P0-stage VSMCs did not
respond to AngII stimulation.
3.2. Interaction with ECMs is necessary for phenotypic change
Since plating P0 cells on laminin-coated dish induced the expression
of smooth muscle marker proteins, we further examined various extra-
cellularmatrices (ECMs) on the phenotypic change of VSMCs. As shown
in Fig. 2A, plating the synthetic type of VSMCs (60%density) on laminin-
coated dish signiﬁcantly enhanced the expression of SMA and calponin
whereas plating the VSMCs on gelatin- or collagen-coated dish did
not induce the expression of SMA and calponin. Plating VSMCs on
laminin-coated dish (60% density) initiated the expression of SMA and
calponin within 24 h (Fig. 2B). In addition, expression of SMA and
calponin was increased in a density-dependent manner. Plating the
VSMCs on laminin-coated dish at low density (10%) could not induce
the expression of SMA and calponin within 24 h. As shown in Fig. 2C,
plating synthetic VSMCs on laminin-coated plates rapidly activated
both Akt and ERK, whereas gelatin could not induce the activation of
Akt and ERK1/2, indicating that laminin-dependent signaling is impor-
tant for phenotypic change of VSMCs.
3.3. ILK plays an essential role in phenotypic conversion of VSMCs
ILK plays an important role in ECM-mediated signaling pathways.
Since the phenotypic conversion of VSMCs requires the interaction
with laminin, we examined the role of ILK in the phenotypic conversion
of VSMCs. As shown in Fig. 3A, silencing ILK completely abolished basal
level of SMA and calponin as well as laminin-dependent expression of
SMA and calponin. In addition, plating the VSMC silencing ILK did not
show AngII-induced contraction of VSMCs, when compared with vector
Fig. 1. Phenotypic conversion of synthetic VSMCs into contractile type. Rat aortic tissue fragments were explanted onto collagen-coated plates. After 7 days of culture, sprouting cells were
designated as P0 and plated on laminin-coated plates. (A) Expression of marker proteins was veriﬁed by western blot analysis; (B) immunocytochemistry at the indicated times. Magni-
ﬁcation, 40×; (C) Each stage of cellswas embedded in collagen gel bead and stimulatedwith AngII. Time-lapse imagewas recorded digitally and contractionwas expressed as % of area out
of initial area. Data are means ± S.D. Asterisks indicate statistical signiﬁcance (P b 0.05).
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strongly stimulated activation of Akt and ERK, we next examined the
effect of ILK on the activation of Akt and ERK. As shown in Fig. 3C–E, si-
lencing ILK signiﬁcantly attenuated laminin-induced activation of Akt
whereas activation of ERK was barely affected.3.4. Akt1 isoform is required for laminin-mediated phenotypic conversion of
VSMCs
Since ILK plays a crucial role in laminin-dependent activation of Akt
but not ERK, we examined the effect of Akt and ERK on the phenotypic
conversion of VSMCs. As shown in Fig. 4A, pharmacological inhibition
of PI3K by LY204002 (50 μM) signiﬁcantly blocked the expression of
SMA and calponin; however, inhibition of ERK signaling pathways by
PD98059 (1 μM) enhanced the expression of SMA and calponin. To
assess the effect of each Akt isoform on phenotypic conversion of
VSMCs, we veriﬁed the expression of each isoform and speciﬁcally si-
lenced each by lentiviral shRNA expression. As shown in Fig. 4B, both
Akt1 and Akt2 isoforms were expressed in VSMCs. Akt1 shRNA effec-
tively silenced Akt1 expression, without signiﬁcantly affecting Akt2
expression, and vice versa for Akt2 shRNA. As shown in Fig. 4C, silencing
Akt1 completely blocked the phenotypic conversion of VSMCs whereas
silencing Akt2 was not effective. Furthermore, silencing the Akt1 iso-
form signiﬁcantly reduced AngII-dependent contraction of VSMCs
whereas silencing Akt2 did not affect AngII-dependent contraction
(Fig. 4D). Since Akt1 regulates laminin-dependent phenotypic conver-
sion of synthetic VSMCs, we next examined the effect of Akt1 silencing
in contractile phenotype of VSMCs on the proliferation. As shown in
Fig. 4E, silencing Akt1 signiﬁcantly induced proliferation of VSMCswhereas silencing of Akt2 did not affect. In addition, silencing Akt1 in-
duced S phase population of the VSMCs (Fig. 4F).
3.5. Akt1 regulates SM22α promoter activity via myocardin expression
Since our results showed that Akt1 was essential for laminin-
stimulated conversion of VSMC phenotype, we explored the effect of
Akt1 on the promoter activity ofmyocardin,which is a critical transcrip-
tional factor for the contractile phenotype of VSMCs. As shown in
Fig. 5A, promoter activity of myocardin was signiﬁcantly elevated in
the contractile phenotype of VSMCs. In addition, the promoter activity
of SM22α, which is a marker protein for the contractile phenotype,
was signiﬁcantly elevated in contractile VSMCs (Fig. 5B). Expression of
myocardin in synthetic VSMCs strongly enhanced the promoter activity
of SM22α (Fig. 5C). Promoter activity ofmyocardin and SM22αwas sig-
niﬁcantly abrogated in VSMCs with silenced Akt1 but not Akt2 (Fig. 5D
and E). As shown in Fig. 5F, defective promoter activity of SM22α in cells
with silenced Akt1 was completely restored by ectopic expression of
myocardin. Likewise, the promoter activity of SMA was also regulated
by myocardin and Akt (Supplemental Fig. S1).
3.6. Neointima formation is accelerated in mice lacking Akt1
To assess the role of Akt1 in the regulation of VSMC phenotype
in vivo, the left common carotid artery (LCCA) was ligated distal to the
aortic arch near the bifurcation for 4 weeks. As shown in Fig. 6A, neoin-
tima formationwas signiﬁcantly augmented in Akt1−/−mice compared
with Akt1+/+ mice. Quantitative analysis showed that neointima area
was elevated about 2-fold in mice lacking Akt1. Expression of SMA
and SM22α was signiﬁcantly reduced in neointimal lesion compared
Fig. 2. Laminin-dependent changes of VSMC phenotype. (A) P0 stage of VSMCswas plated on petri-dishes coatedwith vehicle, gelatin, collagen, or laminin for indicated times. Cells were
harvested and expression of SMAand calponinwas veriﬁedbywestern blot analysis. (B) P0 stage of VSMCswas plated on laminin-coateddishes and time- and dose-dependent expression
of SMA and calponin were examined by western blot analysis.
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artiﬁcial model, we tried to evaluate the role of Akt1 in a pathological
condition such as atherosclerosis. As shown in Fig. 6B, feedingFig. 3. ILK is necessary for laminin-dependent phenotypic conversion of VSMCs and activation o
further cultured for indicated times. (A) Expression of SMA, calponin, and ILK was veriﬁed b
means ± S.D. Asterisks indicate statistical signiﬁcance (P b 0.05). (C) ILK was silenced in P0-s
and ERK was veriﬁed by western blot analysis; and (E) band intensity was quantiﬁed by measApoE−/−Akt1−/−mice a high-fat diet (15 weeks) signiﬁcantly increased
number of cells and showed necrotic core in neointima lesion compared
with ApoE−/−Akt1+/+ mice. In addition, neointima lesion formation inf Akt. ILK was silenced in P0-stage VSMCs. Cells were plated on laminin-coated dishes and
y western blot analysis; and (B) AngII-dependent contraction was quantiﬁed. Data are
tage VSMCs and expression of ILK was veriﬁed by western blotting; (D) activation of Akt
uring pixel intensity. Asterisks indicate statistical signiﬁcance (P b 0.05).
Fig. 4. PI3K/Akt1 is required for laminin-induced phenotypic conversion of VSMCs. (A) P0-stage VSMCswere plated on laminin-coated dishes in the presence or absence of inhibitors. Cells
were harvested at the indicated times and expression of calponin and SMAwas veriﬁed bywestern blot analysis. (B) Each isoform of Aktwas silenced in P0-stage VSMCs and expression of
Akt1 and Akt2was veriﬁed bywestern blot analysis; (C) cells were plated on laminin-coated dishes for the indicated times and expression of SMA and calponinwasmeasured bywestern
blot analysis; and (D)AngII-dependent contractionwas quantiﬁed.Data aremeans±S.D. Asterisks indicate statistical signiﬁcance (P b 0.05). (E) Each isoformof Aktwas silenced in P3-stage
VSMCs and number of cells was counted at the indicated times. Data are means ± S.D. Asterisks indicate statistical signiﬁcance (P b 0.05); and (F) ﬂow cytometry analysis was performed.
Numbers in column represent S phase population.
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(Fig. 6C).
4. Discussion
In the present study, we demonstrated that Akt1 regulates the
phenotypic change of VSMCs through laminin–ILK–Akt1 signaling
axis-dependent expression of myocardin and smooth muscle marker
proteins. In addition, we showed that loss of Akt1 contributed to the
induction of intimal thickening in vivo. Consequently, we propose that
matrix-dependent activation of Akt1 isoform is a potential target for in-
hibition of intimal thickening.
To a great extent, conversion of synthetic VSMCs into the contractile
phenotype resembles the differentiation of proliferating myoblasts into
myotubes during the formation of skeletal muscles. However, unlike
skeletal muscles, contractile VSMCs are able to switch their phenotype
into proliferating VSMCs [19]. Phenotypic switching takes place in ath-
erogenesis, vascular injury, and when vessel fragments are established
in culture [7,20]. Indeed, explanting normal vessel fragments onto
collagen-coated plate derives descent amount of sprouting cells,
which show a proliferative phenotype showing low expression level
of marker proteins for contractile phenotype such as MHC, MLCK,
SM22α, SMA, and calponin (Fig. 1). This result also suggests that rapidly
proliferating VSMCs originates from existing VSMCs in the medial layer
of vessels since adventitial layer was discarded.
Many environmental cues have been reported to play a key role
in the phenotypic change of VSMCs, including insulin-like growth
factor-1 (IGF-1), tumor growth factorβ (TGFβ), mechanical forces,
cell-to-cell interaction and ECM proteins [21]. Among ECM proteins,laminin is a major component of the basementmembrane that normal-
ly surrounds contractile vascular smooth muscle cells. The role of lami-
nin in the phenotypic modulation of VSMCs has also been implicated.
For example, laminin was the most effective ECM for maintaining the
contractile phenotype of VSMCs [6]. Likewise, our results showed that
laminin strongly promoted conversion of the synthetic phenotype of
VSMCs into the contractile phenotype (Figs. 1 and 2). In addition, lami-
nin was expressed in medial layer whereas expression of laminin was
signiﬁcantly reduced in neointimal layer indicating that laminin could
be an environmental cue for phenotypic change of VSMCs (Supplemen-
tal Fig. S2). It is also noteworthy that expression of collagen, which has
no effect onVSMCsdifferentiation,was strongly enhanced in neointimal
lesion in comparison with medial layer. Although laminin plays crucial
role in phenotypic conversion, it seems not to be the sole factor for
the phenotypic conversion. For instance, laminin-induced phenotypic
conversion was not observed in the absence of cell-to-cell interaction
(Fig. 2). Therefore, the multiple interactions with environmental cues
seem to be an important determinant for VSMC phenotype, and the in-
teraction with laminin might be one of the signiﬁcant inducers for
shifting the synthetic phenotype to the contractile phenotype.
Laminins are a family of large heterotrimeric (αβγ) proteins
and major isoform of laminin used in this study was laminin-511
(α5β1γ1) [22]. It also has been reported that laminin-511 exists in tuni-
camedia [23]. Hence, laminin-511 seems to be important for phenotyp-
ic conversion of VSMCs. The binding partner of laminin-511 was not
clearly demonstrated in this study, however, it has been reported that
laminin-511 preferentially interacts with integrin α3β1 in VSMCs [24,
25]. Therefore, it is likely that laminin-dependent activation of β1-
integrin signaling pathways is important for modulating phenotypic
Fig. 5. Akt1 isoform is required for the expression of myocardin and subsequent expression of SM22α. (A) Luciferase-tagged promoter was transfected into P0 (synthetic)- or P3
(contractile)-stage VSMCs, and luciferase activity was measured for promoter activity of myocardin; and (B) promoter activity of SM22α. (C) Promoter activity of SM22αwasmeasured
in P0 (synthetic)-stage VSMCs in the presence or absence of myocardin expression. (D) Either Akt1 or Akt2 was silenced in P3 (contractile)-stage VSMCs and luciferase activity was
measured for promoter activity of myocardin; and (E) promoter activity of SM22α. (F) Akt1 was silenced in P3 (contractile)-stage VSMCs and promoter activity of SM22αwasmeasured
in the presence or absence of myocardin expression. Data are means ± S.D. of three independent experiments (n = 3 for each experiment). Asterisks indicate statistical signiﬁcance
(P b 0.05).
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ing protein in yeast two-hybrid screen [12]. Indeed, ILK seems to be a
key regulatory molecule for laminin-induced phenotypic conversion of
VSMCs (Fig. 3). Several reports support the pivotal role of ILK in
VSMCs. For example, ILK plays a crucial role in the regulation of VSMC
physiologies such as adhesion,migration, and proliferation [26]. In addi-
tion, conditional deletion of ILK in smooth muscle resulted in alteration
of smooth muscle marker gene expression [27], indicating that ILK sig-
naling pathway is linked to the expression of contractile smoothmuscle
marker genes. In line with this, laminin-induced expression of marker
proteins for contractile phenotype of VSMCs such as SMA and SM22α
as well as AngII-dependent contraction was completely abolished in
cells with silenced ILK (Fig. 3). The laminin–integrin–ILK signaling axis
therefore seems to be important for converting VSMCs from the syn-
thetic phenotype to the contractile phenotype aswell as formaintaining
contractile phenotype of VSMCs.
One of the downstream targets of ILK is Akt serine/threonine kinase,
which is involved in a variety of cellular physiologies. ILK activates Akt
by phosphorylation at Ser473 [13]. Likewise, our results showed that
attachment of VSMCs on laminin-coated plates, but not collagen-
coated plates, rapidly induced the phosphorylation of Akt (Fig. 2), and
silencing of ILK resulted in the attenuation of Akt phosphorylation
(Fig. 3). It is also noteworthy that activation of ERK was not affected
by silencing of ILK, indicating that the activation of ERK is independentof ILK activation (Fig. 3D and E). Pharmacological inhibition of PI3K
signiﬁcantly abrogated phenotypic change of VSMCs. In contrast, inhibi-
tion of the ERK stimulated phenotypic change of VSMCs (Fig. 3A). It is
still unclear how inhibition of ERK signaling pathway accelerates
laminin-induced phenotypic change of VSMCs, however, it has been re-
ported that the balance between PI3K/Akt and ERK signaling pathways
is important for maintaining the contractile phenotype of VSMCs. For
instance, strong activation of the ERK signaling pathway by platelet-
derived growth factor (PDGF) rapidly promotes the phenotypic change
of VSMCs from contractile to synthetic [28]. Therefore, it is reasonable
that inhibition of the ERK signaling pathway would accelerate the phe-
notypic change from synthetic to contractile.
In the present study, we emphasized the isoform-speciﬁc regulation
of the VSMC phenotype. Both Akt1 and Akt2 isoforms existed in VSMCs
(Fig. 4B). However, the laminin-induced phenotypic change was only
affected by silencing Akt1 but not Akt2 (Fig. 3C and D). In correlation
with phenotypic changes, promoter activity of myocardin and SM22α
was selectively attenuated by silencing Akt1 but not Akt2 (Fig. 5D and
E). In addition, proliferation of contractile phenotype of VSMCs was se-
lectively facilitated by silencing Akt1 but not Akt2 (Fig. 4E and F). On the
other hand, it has been reported that glucose transporter 4 (GLUT4)
translocation and glucose uptake aremediated in an Akt2-speciﬁc man-
ner [29]. Taken together, it is likely that Akt1 isoform has distinct func-
tions in the regulation of phenotypic changes of VSMCs. However, it is
Fig. 6. Loss of Akt1 enhances intimal hyperplasia. (A) Carotid arteries of mice were ligated for 4 weeks. Left: representative photomicrographs of cross-sections from the carotid arteries
stainedwith hematoxylin and eosin, SMA, and SM22α. Dashed line deﬁnesmedia and neointima layer. Bar, 50 μm; right: quantitative analysis of neointima area. Results are presented as
the ration of neointimal area to media area. n = 6 for each group. (B) Mice were fed a high-fat diet for 15 weeks. Representative photomicrographs of cross-sections from the aortic arch
stainedwith hematoxylin and eosin. Dashed line deﬁnesmedia and neointima layer. Arrows indicate necrotic core. Bar, 50 μm; (C) Left: representative photomicrographs of cross-sections
from the aortic sinus stained with hematoxylin and eosin. Arrows indicate neointima. Bar, 100 μm; right: quantitative analysis of neointima area. Results are presented as the ration of
neointimal area to media area. n = 4 for each group.
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VSMCs. One possible mechanism could be related with the regulation
of myocardin expression or its transcriptional activity (Fig. 5). In line
with this, it has been reported that Akt modulates VSMC phenotype
through regulation of FoxO4 with myocardin [30]. However, isoform
speciﬁc function of Akt in this regulation remains to be elucidated.
The involvement of Akt1 in the process of vascular remodeling has
been implicated in vivo. It has been reported that loss of Akt1 increases
vessel wall inﬂammation to enhance atherosclerosis [31,32]. In addition
to this, we showed that the major population of cells in the neointima
areawas not detected by antibodies against SMA and SM22α, indicating
thatmost of those cellswere synthetic VSMCs (Fig. 6A).We also showed
that inﬁltration of cells into the ﬁbroblast cap lesion signiﬁcantly en-
hanced in mice lacking Akt1 (Fig. 6B). Therefore, it is likely that Akt1
might regulate phenotypic conversion during the neointima formation
in vivo.
In terms of ILK and Akt function, discrepancies remain between pro-
liferation and neointima formation. It has been reported that suppres-
sion of ILK resulted in the inhibition of neointima formation as well as
in the activation of Akt [33]. In linewith this, our results showed that si-
lencing ILK severely blocked proliferation of VSMCs (data not shown). It
is also notable that silencing ILK resulted in complete loss ofmarker pro-
tein for contractile phenotype of VSMCs at the basal level while the ac-
tivation of Akt was moderately affected (Fig. 3). A simple hypothesis
would be the suppression of neointima formation by ablation of ILK
since ILK is important for cell proliferation and migration. However,loss of Akt1 in contractile phenotype of VSMCs clearly enhanced prolif-
eration (Fig. 4E and F). In addition, loss of Akt1 facilitated neointima for-
mation [31]. In line with this, our result showed intimal hyperplasia in
mice lacking Akt1, and these cells were not characterized as contractile
VSMCs (Fig. 6). The plausible interpretation for these discrepancies
could be deduced from cellular context. In synthetic phenotype, loss of
Akt1 fails to acquire contractile phenotype and remains synthetic phe-
notype which shows faster proliferation rate than contractile pheno-
type. In contractile phenotype, loss of Akt1 makes VSMCs susceptible
to phenotypic conversion into synthetic phenotype and acquires intimal
hyperplasia. It is possible that another isoform of Akt replaces the func-
tion of Akt1 in the regulation of VSMC proliferation in both cases. In this
regard, ILK seems to be required for the proliferation of VSMCs unlike
Akt1.
In conclusion, laminin-induced activation of Akt1 isoform plays a
pivotal role in the expression of contractile marker proteins and the
maintenance of the contractile phenotype of VSMCs. Our ﬁndings sup-
port the notion that speciﬁc signaling pathway of Akt1 functions as a
regulator of neointima formation. Therefore, Akt1 may be an important
therapeutic target for occlusive arterial diseases such as restenosis and
atherosclerosis.
Acknowledgements
This work was supported by a grant from the Korean Health
Technology R&D Project, Ministry of Health & Welfare, Republic of
2192 S.J. Yun et al. / Biochimica et Biophysica Acta 1842 (2014) 2184–2192Korea (A120879) and by the National Research Foundation of Korea
(NRF) grant funded by the Korea Government (MEST) (2011-0009395).
Appendix A. Supplementary data
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbadis.2014.08.014.
References
[1] M.R. Alexander, G.K. Owens, Epigenetic control of smoothmuscle cell differentiation
and phenotypic switching in vascular development and disease, Annu. Rev. Physiol.
74 (2012) 13–40.
[2] H. Hao, G. Gabbiani, M.L. Bochaton-Piallat, Arterial smoothmuscle cell heterogeneity:
implications for atherosclerosis and restenosis development, Arterioscler. Thromb.
Vasc. Biol. 23 (2003) 1510–1520.
[3] L.S. Ferreira, S. Gerecht, H.F. Shieh, N. Watson, M.A. Rupnick, S.M. Dallabrida, G.
Vunjak-Novakovic, R. Langer, Vascular progenitor cells isolated from human embry-
onic stem cells give rise to endothelial and smooth muscle like cells and form vas-
cular networks in vivo, Circ. Res. 101 (2007) 286–294.
[4] J. Chen, C.M. Kitchen, J.W. Streb, J.M. Miano, Myocardin: a component of a molecular
switch for smooth muscle differentiation, J. Mol. Cell. Cardiol. 34 (2002) 1345–1356.
[5] E.E. Creemers, L.B. Sutherland, J. McAnally, J.A. Richardson, E.N. Olson, Myocardin is a
direct transcriptional target of Mef2, Tead and Foxo proteins during cardiovascular
development, Development 133 (2006) 4245–4256.
[6] K. Hayashi, H. Saga, Y. Chimori, K. Kimura, Y. Yamanaka, K. Sobue, Differentiated
phenotype of smooth muscle cells depends on signaling pathways through
insulin-like growth factors and phosphatidylinositol 3-kinase, J. Biol. Chem. 273
(1998) 28860–28867.
[7] J. Chamley-Campbell, G.R. Campbell, R. Ross, The smooth muscle cell in culture,
Physiol. Rev. 59 (1979) 1–61.
[8] A. Hultgardh-Nilsson, M. Durbeej, Role of the extracellular matrix and its receptors
in smooth muscle cell function: implications in vascular development and disease,
Curr. Opin. Lipidol. 18 (2007) 540–545.
[9] U. Hedin, J. Thyberg, Plasma ﬁbronectin promotes modulation of arterial smooth-
muscle cells from contractile to synthetic phenotype, Differentiation 33 (1987)
239–246 (research in biological diversity).
[10] U. Hedin, B.A. Bottger, E. Forsberg, S. Johansson, J. Thyberg, Diverse effects of ﬁbro-
nectin and laminin on phenotypic properties of cultured arterial smooth muscle
cells, J. Cell Biol. 107 (1988) 307–319.
[11] M.A. Arnaout, S.L. Goodman, J.P. Xiong, Structure and mechanics of integrin-based
cell adhesion, Curr. Opin. Cell Biol. 19 (2007) 495–507.
[12] G.E. Hannigan, P.C. McDonald, M.P. Walsh, S. Dedhar, Integrin-linked kinase: not so
‘pseudo’ after all, Oncogene 30 (2011) 4375–4385.
[13] D.K. Lynch, C.A. Ellis, P.A. Edwards, I.D. Hiles, Integrin-linked kinase regulates phos-
phorylation of serine 473 of protein kinase B by an indirect mechanism, Oncogene
18 (1999) 8024–8032.
[14] C. Wu, S. Dedhar, Integrin-linked kinase (ILK) and its interactors: a new paradigm
for the coupling of extracellular matrix to actin cytoskeleton and signaling com-
plexes, J. Cell Biol. 155 (2001) 505–510.
[15] S.R. Datta, A. Brunet, M.E. Greenberg, Cellular survival: a play in three Akts, Genes
Dev. 13 (1999) 2905–2927.[16] H. Cho, J. Mu, J.K. Kim, J.L. Thorvaldsen, Q. Chu, E.B. Crenshaw III, K.H. Kaestner, M.S.
Bartolomei, G.I. Shulman, M.J. Birnbaum, Insulin resistance and a diabetes mellitus-
like syndrome in mice lacking the protein kinase Akt2 (PKB beta), Science 292
(2001) 1728–1731 (New York, N.Y.).
[17] H. Cho, J.L. Thorvaldsen, Q. Chu, F. Feng, M.J. Birnbaum, Akt1/PKBalpha is required
for normal growth but dispensable for maintenance of glucose homeostasis in
mice, J. Biol. Chem. 276 (2001) 38349–38352.
[18] R.M. Easton, H. Cho, K. Roovers, D.W. Shineman, M. Mizrahi, M.S. Forman, V.M. Lee,
M. Szabolcs, R. de Jong, T. Oltersdorf, T. Ludwig, A. Efstratiadis, M.J. Birnbaum, Role
for Akt3/protein kinase Bgamma in attainment of normal brain size, Mol. Cell.
Biol. 25 (2005) 1869–1878.
[19] K. Kawai-Kowase, G.K. Owens, Multiple repressor pathways contribute to pheno-
typic switching of vascular smooth muscle cells, Am. J. Physiol. Cell Physiol. 292
(2007) C59–C69.
[20] G.R. Campbell, J.H. Chamley-Campbell, Invited review: the cellular pathobiology of
atherosclerosis, Pathology 13 (1981) 423–440.
[21] G.K. Owens, Regulation of differentiation of vascular smooth muscle cells, Physiol.
Rev. 75 (1995) 487–517.
[22] Z. Wondimu, G. Gorfu, T. Kawataki, S. Smirnov, P. Yurchenco, K. Tryggvason, M.
Patarroyo, Characterization of commercial laminin preparations from human
placenta in comparison to recombinant laminins 2 (alpha2beta1gamma1), 8
(alpha4beta1gamma1), 10 (alpha5beta1gamma1), Matrix Biol. 25 (2006) 89–93.
[23] U. Rauch, A. Saxena, S. Lorkowski, J. Rauterberg, H. Bjorkbacka, M. Durbeej, A.
Hultgardh-Nilsson, Laminin isoforms in atherosclerotic arteries from mice and
man, Histol. Histopathol. 26 (2011) 711–724.
[24] A.A. de Melker, L.M. Sterk, G.O. Delwel, D.L. Fles, H. Daams, J.J. Weening, A.
Sonnenberg, The A and B variants of the alpha 3 integrin subunit: tissue distribution
and functional characterization, Lab. Investig. 76 (1997) 547–563.
[25] Y. Kikkawa, N. Sanzen, H. Fujiwara, A. Sonnenberg, K. Sekiguchi, Integrin binding
speciﬁcity of laminin-10/11: laminin-10/11 are recognized by alpha 3 beta 1,
alpha 6 beta 1 and alpha 6 beta 4 integrins, J. Cell Sci. 113 (Pt 5) (2000) 869–876.
[26] B. Ho, M.P. Bendeck, Integrin linked kinase (ILK) expression and function in vascular
smooth muscle cells, Cell Adhes. Migr. 3 (2009) 174–176.
[27] D. Shen, J. Li, J.J. Lepore, T.J. Anderson, S. Sinha, A.Y. Lin, L. Cheng, E.D. Cohen, J.D.
Roberts Jr., S. Dedhar, M.S. Parmacek, R.E. Gerszten, Aortic aneurysm generation in
mice with targeted deletion of integrin-linked kinase in vascular smooth muscle
cells, Circ. Res. 109 (2011) 616–628.
[28] K. Hayashi, M. Takahashi, K. Kimura, W. Nishida, H. Saga, K. Sobue, Changes in the
balance of phosphoinositide 3-kinase/protein kinase B (Akt) and the mitogen-
activated protein kinases (ERK/p38MAPK) determine a phenotype of visceral and
vascular smooth muscle cells, J. Cell Biol. 145 (1999) 727–740.
[29] S.S. Bae, H. Cho, J. Mu, M.J. Birnbaum, Isoform-speciﬁc regulation of insulin-
dependent glucose uptake by Akt/protein kinase B, J. Biol. Chem. 278 (2003)
49530–49536.
[30] Z.P. Liu, Z. Wang, H. Yanagisawa, E.N. Olson, Phenotypic modulation of smooth mus-
cle cells through interaction of Foxo4 and myocardin, Dev. Cell 9 (2005) 261–270.
[31] C. Fernandez-Hernando, E. Ackah, J. Yu, Y. Suarez, T.Murata, Y. Iwakiri, J. Prendergast,
R.Q. Miao, M.J. Birnbaum,W.C. Sessa, Loss of Akt1 leads to severe atherosclerosis and
occlusive coronary artery disease, Cell Metab. 6 (2007) 446–457.
[32] C. Fernandez-Hernando, L. Jozsef, D. Jenkins, A. Di Lorenzo, W.C. Sessa, Absence of
Akt1 reduces vascular smooth muscle cell migration and survival and induces fea-
tures of plaque vulnerability and cardiac dysfunction during atherosclerosis,
Arterioscler. Thromb. Vasc. Biol. 29 (2009) 2033–2040.
[33] A. Dwivedi, G.B. Sala-Newby, S.J. George, Regulation of cell-matrix contacts and
beta-catenin signaling in VSMC by integrin-linked kinase: implications for intimal
thickening, Basic Res. Cardiol. 103 (2008) 244–256.
